Trends in AIDS and mortality in HIV-infected subjects with hemophilia from 1985 to 2003: the competing risks for death between AIDS and liver disease.
J Acquir Immune Defic Syndr. 2006.
PMID: 16652037
Search Page
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 1982 | 1 |
| 1984 | 1 |
| 1985 | 3 |
| 1986 | 5 |
| 1987 | 24 |
| 1988 | 31 |
| 1989 | 32 |
| 1990 | 51 |
| 1991 | 55 |
| 1992 | 70 |
| 1993 | 94 |
| 1994 | 88 |
| 1995 | 90 |
| 1996 | 95 |
| 1997 | 103 |
| 1998 | 123 |
| 1999 | 118 |
| 2000 | 126 |
| 2001 | 116 |
| 2002 | 159 |
| 2003 | 172 |
| 2004 | 225 |
| 2005 | 252 |
| 2006 | 231 |
| 2007 | 239 |
| 2008 | 243 |
| 2009 | 190 |
| 2010 | 209 |
| 2011 | 235 |
| 2012 | 293 |
| 2013 | 300 |
| 2014 | 352 |
| 2015 | 327 |
| 2016 | 382 |
| 2017 | 366 |
| 2018 | 318 |
| 2019 | 316 |
| 2020 | 319 |
| 2021 | 300 |
| 2022 | 266 |
| 2023 | 250 |
| 2024 | 213 |
| 2025 | 236 |
| 2026 | 59 |
Search Results
7,107 results
Results by year
Citations
5
articles
found by citation matching
Excess mortality from liver disease and other non-AIDS-related diseases among HIV-infected individuals in Italy.
J Acquir Immune Defic Syndr. 2002.
PMID: 11782600
No abstract available.
Non-Alcoholic Fatty Liver Disease and HIV/AIDS: A New Way of Modulation of Cardiovascular Risk.
AIDS Rev. 2017.
PMID: 29271970
Review.
Search results
Page 1
HIV and liver disease.
AIDS Rev. 2022;25(2):87-96. doi: 10.24875/AIDSRev.M22000052.
AIDS Rev. 2022.
PMID: 35901073
Review.
Liver-related diseases are associated with the high levels of morbidity and mortality in people living with HIV. ...On the other hand, some antiretroviral drugs may have a beneficial effect in reversing liver fibrosis in patients with HIV and ch …
Liver-related diseases are associated with the high levels of morbidity and mortality in people living with HIV. ...On …
Non-Alcoholic Fatty Liver Disease and HIV/AIDS: A New Way of Modulation of Cardiovascular Risk.
AIDS Rev. 2017 Oct-Dec;19(4):190-197.
AIDS Rev. 2017.
PMID: 29271970
Review.
Importantly, HIV and non-alcoholic fatty liver disease are both associated with increased risk of cardiovascular disease. ...Further research is needed to address the best strategies in the management of cardiovascular disease in patients with …
Importantly, HIV and non-alcoholic fatty liver disease are both associated with increased risk of cardiovascular dis …
Communicable and noncommunicable liver disease in HIV.
Curr Opin HIV AIDS. 2021 May 1;16(3):152-155. doi: 10.1097/COH.0000000000000675.
Curr Opin HIV AIDS. 2021.
PMID: 33783404
Review.
PURPOSE OF REVIEW: The aim of this study was to highlight the profound changes in the cause in chronic liver disease in HIV-infected individuals. RECENT FINDINGS: Hepatitis C virus (HCV) has been transformed into a curable viral infection by highly effective …
PURPOSE OF REVIEW: The aim of this study was to highlight the profound changes in the cause in chronic liver disease in HIV …
A gathering storm: HIV infection and nonalcoholic fatty liver disease in low and middle-income countries.
AIDS. 2019 Jun 1;33(7):1105-1115. doi: 10.1097/QAD.0000000000002161.
AIDS. 2019.
PMID: 31045941
Review.
: Despite the decreasing total incidence of liver-related deaths, liver disease remains one of the major non-AIDS causes of morbidity and mortality amongst people living with HIV, and a significant proportion of liver disease in th …
: Despite the decreasing total incidence of liver-related deaths, liver disease remains one of the major non-AIDS …
Current and Investigational Biomarkers of Liver Disease in HIV-HBV Co-infection.
Curr HIV/AIDS Rep. 2025 Sep 27;22(1):46. doi: 10.1007/s11904-025-00756-x.
Curr HIV/AIDS Rep. 2025.
PMID: 41014390
Review.
PURPOSE OF REVIEW: Coinfection with HIV-HBV results in increased rate of liver disease progression through immune and metabolic dysfunction. ...Simple tests such as FIB-4 and APRI have poor diagnostic utility for significant fibrosis or disease monitor …
PURPOSE OF REVIEW: Coinfection with HIV-HBV results in increased rate of liver disease progression through immune and m …
Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) in HIV.
Curr HIV/AIDS Rep. 2017 Apr;14(2):47-53. doi: 10.1007/s11904-017-0351-2.
Curr HIV/AIDS Rep. 2017.
PMID: 28284005
Review.
With availability of antiretroviral combination therapy, life expectancy has improved dramatically and as a consequence the spectrum of liver disease is changing. Increased reports on the development of non-alcoholic fatty liver disease (NAFLD) or non- …
With availability of antiretroviral combination therapy, life expectancy has improved dramatically and as a consequence the spectrum of l …
Liver disease, HIV and aging.
Sex Health. 2011 Dec;8(4):512-20. doi: 10.1071/SH10163.
Sex Health. 2011.
PMID: 22127037
Free PMC article.
Review.
This review will focus on the current understanding of liver disease in older (>50 years old) HIV-negative individuals and in HIV-infected individuals. Areas for future research in the area of HIV, liver disease and aging will a …
This review will focus on the current understanding of liver disease in older (>50 years old) HIV-negative individua …
NASH in HIV.
Curr HIV/AIDS Rep. 2020 Dec;17(6):601-614. doi: 10.1007/s11904-020-00531-0.
Curr HIV/AIDS Rep. 2020.
PMID: 32984925
Review.
PURPOSE OF REVIEW: Aging-related comorbidities, including liver disease, represent the main drivers of morbidity and mortality in people with HIV (PWH). Nonalcoholic fatty liver disease (NAFLD) seems a frequent comorbidity in aging PWH nowadays. …
PURPOSE OF REVIEW: Aging-related comorbidities, including liver disease, represent the main drivers of morbidity and mortality …
Cardiovascular Outcomes Among Persons with HIV and Nonalcoholic Fatty Liver Disease.
AIDS. 2023 Jul;37(8):1329-1331. doi: 10.1097/QAD.0000000000003562.
AIDS. 2023.
PMID: 37822712
Free PMC article.
No abstract available.
Prevalence and Associated Factors of Non-Alcoholic Fatty Liver Disease in People Living with HIV-1.
Curr HIV Res. 2025;23(2):121-132. doi: 10.2174/011570162X340918250312040500.
Curr HIV Res. 2025.
PMID: 40129156
BACKGROUND: Modern antiretroviral therapy (ART) prevents disease progression in people living with HIV. Due to the increasing age of people living with HIV, the detection and management of comorbidities has become more important. OBJECTIVE: In this study, we …
BACKGROUND: Modern antiretroviral therapy (ART) prevents disease progression in people living with HIV. Due to the increasing …
Cite